Improving demand in major end markets augurs well for The Zacks Chemicals Specialty industry. ESI, FUL, KWR and MTX lean on cost cuts and efficiency moves to offset persistent inflation pressures.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Fifth Third Bancorp increased its holdings in shares of H. B. Fuller Company (NYSE: FUL) by 3,222.9% in the undefined quarter, according to the company in its most recent filing with the Securities an
Dimensional Fund Advisors LP raised its stake in H. B. Fuller Company (NYSE: FUL) by 5.4% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange
H. B. Fuller (FUL) reported earnings 30 days ago. What's next for the stock?
Investors interested in Chemical - Specialty stocks are likely familiar with H. B. Fuller (FUL) and Novozymes A/S (NVZMY).
CLDT, PARR, ARCO, CAL and FUL stand out with attractive EV-to-EBITDA ratios and strong earnings outlook.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

H.B. Fuller Announces Quarterly Dividend

12:00pm, Thursday, 16'th Jul 2026
H.B. Fuller Company (NYSE: FUL) today announced that its Board of Directors declared a regular quarterly cash dividend of $0.2450 per share of common stock, pay

H.B. Fuller Announces Quarterly Dividend

11:12am, Thursday, 16'th Jul 2026
ST. PAUL, Minn.--(BUSINESS WIRE)--H.B. Fuller Company (NYSE: FUL) today announced that its Board of Directors declared a regular quarterly cash dividend of $0.2450 per share of common stock, payable o
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
FUL is tapping medical, aerospace and pricing trends to support margins, but volume weakness still clouds its path to stronger growth.
FUL trades near the low end of its five-year valuation range as improving earnings meet volume, inflation and leverage risks tied to its medical-market expansion.
FUL's outlook rests on pricing, margins and portfolio reshaping as medical expansion and M&A aim to offset uneven demand across key end markets.
Investors interested in stocks from the Chemical - Specialty sector have probably already heard of H. B. Fuller (FUL) and PPG Industries (PPG).
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE